The US Food and Drug Administration (FDA) has asked the US District Court for the District of Columbia for authority to impose fines on the American Red Cross for blood product safety violations. In December, the FDA released a statement saying that the Red Cross had failed to improve its safety record despite signing a 1993 court document promising to do so.
In early 2000, the FDA reported violations at Red Cross headquarters in Washington, including incorrect labeling and release of blood potentially contaminated with cytomegalovirus. The agency also cited inadequate quarantine and premature release of blood.
Vastag B. FDA Chastises Red Cross. JAMA. 2002;287(3):308. doi:10.1001/jama.287.3.308-JHA10014-3-1
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: